BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 7209107)

  • 1. [Correlations between prolactin and somatotropic hormone in human breast cancer].
    Larrad Jiménez A; Caballero Asensi A; Estévez Molina M
    Rev Esp Oncol; 1980; 27(1):29-52. PubMed ID: 7209107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Correlations between PRL and 17-beta-E in human breast cancer].
    Larrad Jiménez A; Ruiz-Tartas A; Zapatero Gaviria J; López Lazareno N
    Rev Esp Oncol; 1984; 31(2):279-87. PubMed ID: 6549590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated growth hormone levels in sera from breast cancer patients.
    Emerman JT; Leahy M; Gout PW; Bruchovsky N
    Horm Metab Res; 1985 Aug; 17(8):421-4. PubMed ID: 4054832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pituitary hormone level in breast cancer patients].
    Agranat VZ; Valiura AV; Nikogosian GA
    Med Radiol (Mosk); 1981 Mar; 26(3):3-8. PubMed ID: 6783807
    [No Abstract]   [Full Text] [Related]  

  • 5. [Prolactin and human cancer of the breast. I. Levels of correlation].
    Cueto Ladrón de Guevara J; Villalba Moreno J; García Puche JL; Pedraza V
    Rev Esp Oncol; 1985; 32(3):439-58. PubMed ID: 3870536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disordered nocturnal prolactin regulation in women with breast cancer.
    Malarkey WB; Schroeder LL; Stevens VC; James AG; Lanese RR
    Cancer Res; 1977 Dec; 37(12):4650-4. PubMed ID: 922745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Plasma-prolactin concentrations in breast cancer at various stages, in mastopathy and other malignant tumors].
    Holtkamp W; von Heyden D; Rauschecker H; Nagel GA
    Schweiz Med Wochenschr; 1983 Oct; 113(41):1513-20. PubMed ID: 6635641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of a low-fat diet on hormone levels in women with cystic breast disease. II. Serum radioimmunoassayable prolactin and growth hormone and bioactive lactogenic hormones.
    Rose DP; Cohen LA; Berke B; Boyar AP
    J Natl Cancer Inst; 1987 Apr; 78(4):627-31. PubMed ID: 3470539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormone concentrations in postmenopausal patients with breast cancer.
    Jones MK; Ramsay ID; Booth M; Collins WP
    Clin Oncol; 1977 Jun; 3(2):177-81. PubMed ID: 872471
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of menopause and hysterectomy on systemic vascular endothelial growth factor in women undergoing surgery for breast cancer.
    Lowery AJ; Sweeney KJ; Molloy AP; Hennessy E; Curran C; Kerin MJ
    BMC Cancer; 2008 Sep; 8():279. PubMed ID: 18826631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of mastectomy on the prolactin level in the blood].
    Nikogosian GA
    Med Radiol (Mosk); 1981 Mar; 26(3):8-13. PubMed ID: 7219111
    [No Abstract]   [Full Text] [Related]  

  • 12. The basal and TRH stimulated levels of prolactin in low risk climacteric patients with increased breast density: a matched pair case control trial.
    Soysal S; Soysal ME; Karabulut N; Gul N; Gezgin T
    Maturitas; 2006 May; 54(2):103-9. PubMed ID: 16530361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum leptin, prolactin and vascular endothelial growth factor (VEGF) levels in patients with breast cancer.
    Coskun U; Günel N; Toruner FB; Sancak B; Onuk E; Bayram O; Cengiz O; Yilmaz E; Elbeg S; Ozkan S
    Neoplasma; 2003; 50(1):41-6. PubMed ID: 12687277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Importance of serum prolactin determination in metastatic breast cancer patients.
    Mujagić Z; Mujagić H
    Croat Med J; 2004 Apr; 45(2):176-80. PubMed ID: 15103755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory action on GHRH-induced GH secretion of chronic tamoxifen treatment in breast cancer.
    De Marinis L; Mancini A; Izzi D; Bianchi A; Giampietro A; Fusco A; Liberale I; Rossi S; Valle D
    Clin Endocrinol (Oxf); 2000 Jun; 52(6):681-5. PubMed ID: 10848871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hypophyseal hormones in young patients with breast cancer].
    Chobanian NS; Kushlinskiĭ NE; Bassalyk LS; Kuzmina ZV; Gershteĭn ES; Saveléva EV; Baryshnikov AIu; Kadagidze ZG
    Klin Med (Mosk); 1994; 72(3):37-40. PubMed ID: 7990352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolactin dependence in human breast cancer.
    Hobbs JR; Salih H
    Proc R Soc Med; 1973 Sep; 66(9):866. PubMed ID: 4805084
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pre- and postoperative differences in the circadian secretion of prolactin in carcinoma of the human breast].
    Larrad Jiménez A; Caballero Asensi A; López Lazareno N
    Rev Esp Oncol; 1983; 30(2):139-69. PubMed ID: 6680777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No association between serum levels of insulin-like growth factor-I, vascular endothelial growth factor, prolactin and clinicopathological characteristics of breast carcinoma after surgery.
    Sancak B; Coskun U; Gunel N; Onuk E; Cihan A; Karamercan A; Yildirim Y; Ozkan S
    Intern Med J; 2004 Jun; 34(6):310-5. PubMed ID: 15228391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Blood prolactin levels and functional status of the sympatho-adrenal system during complex treatment of breast cancer].
    Sidorenko LN; Korovin KF; Popova SP; Egor'kova AS; Shpanskaia LS
    Vestn Khir Im I I Grek; 1982 Aug; 129(8):13-5. PubMed ID: 7135749
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.